CUSIP 68622P109 · who reports it, how much, and how much it matters to them
26 of the 720 hedge fund managers we track reported shares of Oric Pharmaceuticals, Inc. (Nasdaq: ORIC) on Form 13F for 30 June 2026. Between them they reported USD 350m. The largest position belongs to ECOR1 Capital, at USD 73m. The manager with the most riding on it is Aihc Capital Management, where it is 39.8% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | ECOR1 Capital3 funds on PPLI.com | USD 73m | 3.5% |
| 2 | Viking Global Investors4 funds on PPLI.com | USD 56m | 0.2% |
| 3 | Aihc Capital Management1 fund on PPLI.com | USD 41m | 39.8% |
| 4 | Alkeon Capital Management19 funds on PPLI.com | USD 40m | 0.1% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 28m | 0.0% |
| 6 | Orbimed Advisors1 fund on PPLI.com | USD 22m | 0.4% |
| 7 | D. E. Shaw & Co.15 funds on PPLI.com | USD 17m | 0.0% |
| 8 | Braidwell12 funds on PPLI.com | USD 13m | 0.5% |
| 9 | Adage Capital Management1 fund on PPLI.com | USD 11m | 0.0% |
| 10 | Sphera Funds Management1 fund on PPLI.com | USD 8.2m | 1.1% |
| 11 | Millennium Management6 funds on PPLI.com | USD 7.6m | 0.0% |
| 12 | Two Sigma Investments35 funds on PPLI.com | USD 6.5m | 0.0% |
| 13 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 6.3m | 0.3% |
| 14 | Superstring Capital Management1 fund on PPLI.com | USD 4.4m | 2.8% |
| 15 | Redmile Group10 funds on PPLI.com | USD 3.9m | 0.3% |
| 16 | Boxer Capital Management1 fund on PPLI.com | USD 3.8m | 0.3% |
| 17 | Squarepoint Ops7 funds on PPLI.com | USD 3.7m | 0.0% |
| 18 | Atom Investors1 fund on PPLI.com | USD 1.4m | 0.1% |
| 19 | Engineers Gate Manager1 fund on PPLI.com | USD 694,000 | 0.0% |
| 20 | Tudor Investment Corporation10 funds on PPLI.com | USD 459,000 | 0.0% |
| 21 | LMR Partners2 funds on PPLI.com | USD 382,000 | 0.0% |
| 22 | Brevan Howard Capital Management39 funds on PPLI.com | USD 332,000 | 0.0% |
| 23 | Balyasny Asset Management25 funds on PPLI.com | USD 262,000 | 0.0% |
| 24 | Jain Global1 fund on PPLI.com | USD 191,000 | 0.0% |
| 25 | The Quarry1 fund on PPLI.com | USD 182,000 | 0.0% |
| 26 | Prelude Capital Management9 funds on PPLI.com | USD 122,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Aihc Capital Management | USD 41m | 39.8% |
| 2 | ECOR1 Capital | USD 73m | 3.5% |
| 3 | Superstring Capital Management | USD 4.4m | 2.8% |
| 4 | Sphera Funds Management | USD 8.2m | 1.1% |
| 5 | Braidwell | USD 13m | 0.5% |
| 6 | Orbimed Advisors | USD 22m | 0.4% |
| 7 | Boxer Capital Management | USD 3.8m | 0.3% |
| 8 | Arrowmark Colorado Holdings | USD 6.3m | 0.3% |
| 9 | Redmile Group | USD 3.9m | 0.3% |
| 10 | Viking Global Investors | USD 56m | 0.2% |
Oric Pharmaceuticals, Inc. trades under the symbol ORIC on the Nasdaq. Its CUSIP, the code used on Form 13F, is 68622P109.
26 of the 720 hedge fund managers PPLI.com tracks reported Oric Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by ECOR1 Capital (USD 73m), Viking Global Investors (USD 56m), Aihc Capital Management (USD 41m), Alkeon Capital Management (USD 40m) and Citadel Advisors (USD 28m).
26 managers in our coverage reported it, and between them they run 262 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Aihc Capital Management, where the position was 39.8% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Oric Pharmaceuticals, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.